TL

Trevor Lockett

Rhythm Biosciences Limited | Non-Executive Director
Dr Lockett has postdoctoral experience at the Rockefeller University in New York. With over 30 years of research experience, predominantly at the CSIRO, Dr Lockett has led research efforts in the areas of prostate cancer gene therapy, colorectal cancer prevention and the promotion of gastrointestinal health. In his role as Theme Leader, Colorectal Cancer and Gut Health, Dr Lockett oversaw the research efforts which led to the technology that is to become ColoSTAT.

Company and Role

Company
Title
Tenure
Since
RHY
RHY
Rhythm Biosciences Limited
  • Non-Executive Director
5yrs, 10mthNov 2018

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
RHY
RHY
Rhythm Biosciences Limited
31/07/241,678,3001,291,000193,650N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
RHY
RHY
Rhythm Biosciences Limited
31/07/24
Expiry
252,000$0.053$13,356Options expired
RHY
RHY
Rhythm Biosciences Limited
21/03/24
Issued
387,300$0.100$38,730Rights issue
RHY
RHY
Rhythm Biosciences Limited
21/03/24
Issued
193,650$0.100$19,365Rights issue
RHY
RHY
Rhythm Biosciences Limited
08/08/23
Buy
1,125,000$0.200$225,000Exercise of options
RHY
RHY
Rhythm Biosciences Limited
08/08/23
Exercise
1,125,000$0.200$225,000Exercise of options